This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2022 Feb 1;176(2):131-132.

doi: 10.1001/jamapediatrics.2021.4580.

High Drug Costs Hurt Health Outcomes-One Way or Another

Stephen M Downs¹

Affiliations

PMID: 34779826
DOI: 10.1001/jamapediatrics.2021.4580

Editorial

High Drug Costs Hurt Health Outcomes-One Way or Another

Stephen M Downs. JAMA Pediatr. 2022.

. 2022 Feb 1;176(2):131-132.

doi: 10.1001/jamapediatrics.2021.4580.

Author

Stephen M Downs¹

Affiliation

¹ Wake Forest School of Medicine, Center for Biomedical Informatics, Winston Salem, North Carolina.

PMID: 34779826
DOI: 10.1001/jamapediatrics.2021.4580

No abstract available

PubMed Disclaimer

Comment on

Cost Utility of Lifelong Immunoglobulin Replacement Therapy vs Hematopoietic Stem Cell Transplant to Treat Agammaglobulinemia.
Sun D, Heimall JR, Greenhawt MJ, Bunin NJ, Shaker MS, Romberg N. Sun D, et al. JAMA Pediatr. 2022 Feb 1;176(2):176-184. doi: 10.1001/jamapediatrics.2021.4583. JAMA Pediatr. 2022. PMID: 34779842 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems